Product Info Summary
SKU: | PROTQ01780 |
---|---|
Size: | 5ug, 20ug, 1mg |
Origin Species: | Human |
Source: | Sf9 insect cells |
Application: | WB |
Customers Who Bought This Also Bought
Product info
Product Name
EXOSC10 Human Exosome Component 10 Human Recombinant Protein
View all Exosome component 10 recombinant proteins
SKU/Catalog Number
PROTQ01780
Size
5ug, 20ug, 1mg
Description
EXOSC10 Human Recombinant produced in SF9 is a glycosylated, polypeptide chain having a molecular mass of 102 kDa. EXOSC10 is expressed with a -6xHis tag and purified by proprietary chromatographic techniques. Applications: Western blot with monoclonal anti-hexa-His-tag antibody & polymyositis patient sera.
Storage & Handling
Store at 4°C if entire vial will be used within 2-4 weeks. Store frozen at -20°C for longer periods of time.Avoid multiple freeze-thaw cycles.
Cite This Product
EXOSC10 Human Exosome Component 10 Human Recombinant Protein (Boster Biological Technology, Pleasanton CA, USA, Catalog # PROTQ01780)
Form
Sterile Filtered clear solution.
Formulation
EXOSC10 is supplied in 20mM HEPES, pH-7.5, 100mM NaCl, 0.01mM EDTA, 0.02% SDS.
Purity
Greater than 95% as determined by SDS-PAGE.
Assay dilution & Images
Validation Images & Assay Conditions
![recombinant protein thumbnail_1 recombinant protein thumbnail_1](https://www.bosterbio.com/media/catalog/product/r/e/recombinant-protein-thumbnail_1.png)
Click image to see more details
Recombinant protein fun image
Protein Target Info & Infographic
Gene/Protein Information For EXOSC10 (Source: Uniprot.org, NCBI)
Gene Name
EXOSC10
Full Name
Exosome component 10
Weight
Alternative Names
autoantigen PM-SCL; EC 3.1.13.-; exosome component 10; P100 polymyositis-scleroderma overlap syndrome-associated autoantigen; p2; p3; p4; PM/Scl-100Autoantigen PM/Scl 2; PM-Scl; PMSCL2PMSCL; polymyositis/scleroderma autoantigen 2 (100kD); Polymyositis/scleroderma autoantigen 2; polymyositis/scleroderma autoantigen 2, 100kDa; RRP6; Rrp6p; RRP6Polymyositis/scleroderma autoantigen 100 kDa EXOSC10 PM-Scl, PM/Scl-100, PMSCL, PMSCL2, RRP6, Rrp6p, p2, p3, p4 exosome component 10 exosome component 10|P100 polymyositis-scleroderma overlap syndrome-associated autoantigen|autoantigen PM-SCL|polymyositis/scleroderma autoantigen 100 kDa|polymyositis/scleroderma autoantigen 2
*If product is indicated to react with multiple species, protein information is based on the gene entry specified above in "Species".For more info on EXOSC10, check out the EXOSC10 Infographic
![EXOSC10 infographic](/media/images/gene-infographic-example.jpg)
We have 30,000+ of these available, one for each gene! Check them out.
In this infographic, you will see the following information for EXOSC10: database IDs, superfamily, protein function, synonyms, molecular weight, chromosomal locations, tissues of expression, subcellular locations, post-translational modifications, and related diseases, research areas & pathways. If you want to see more information included, or would like to contribute to it and be acknowledged, please contact us at [email protected].
Specific Publications For EXOSC10 Human Exosome Component 10 Human Recombinant Protein (PROTQ01780)
Hello CJ!
No publications found for PROTQ01780
*Do you have publications using this product? Share with us and receive a reward. Ask us for more details.
Recommended Resources
Here are featured tools and databases that you might find useful.
- Boster's Pathways Library
- Protein Databases
- Bioscience Research Protocol Resources
- Data Processing & Analysis Software
- Photo Editing Software
- Scientific Literature Resources
- Research Paper Management Tools
- Molecular Biology Software
- Primer Design Tools
- Bioinformatics Tools
- Phylogenetic Tree Analysis
Customer Reviews
Have you used EXOSC10 Human Exosome Component 10 Human Recombinant Protein?
Submit a review and receive an Amazon gift card.
- $30 for a review with an image
0 Reviews For EXOSC10 Human Exosome Component 10 Human Recombinant Protein
Customer Q&As
Have a question?
Find answers in Q&As, reviews.
Can't find your answer?
Submit your question